Boomerang Portfolio Company Closes Add-On Acquisition, Expanding the Platform's Market Reach & Capabilities for Health Systems Across the Country NASHVILLE, Tenn., Dec. 16, 2025 /PRNewswire/ -- Enjoin ...

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

LPUs grant owners a share in the partnership's income, avoiding double taxation. MLPs distribute available cash to unit holders after deducting maintenance capital. Limited partners only risk losing ...

A lumbosacral spine X-ray is an imaging test that helps your doctor view the bones of your lower back. It uses small amounts of electromagnetic radiation to help healthcare professionals evaluate bone ...